Search

Your search keyword '"Off-Label Use ethics"' showing total 6 results
Start Over Descriptor "Off-Label Use ethics" Publisher british medical association
6 results on '"Off-Label Use ethics"'

1. Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide.

Author

Dyer O

Subjects
Diabetes Mellitus, Type 2 drug therapy, Drug Industry ethics, Fraud, Humans, Hypoglycemic Agents adverse effects, Hypoglycemic Agents therapeutic use, Liraglutide adverse effects, Liraglutide therapeutic use, Neoplasms chemically induced, Neoplasms epidemiology, Off-Label Use economics, Off-Label Use ethics, Off-Label Use legislation & jurisprudence, Professional Misconduct ethics, United States, United States Food and Drug Administration, Drug Industry economics, Drug Industry legislation & jurisprudence, Hypoglycemic Agents economics, Liraglutide economics, Professional Misconduct legislation & jurisprudence
Published
2017
Full Text
View/download PDF

2. GMC is criticised for refusing to disclose reasons behind its advice to support prescribing for Lucentis rather than Avastin for wet AMD.

Author

Cohen D

Subjects
Bevacizumab, Ethics, Medical, Humans, Off-Label Use legislation & jurisprudence, Ranibizumab, Treatment Outcome, United Kingdom, Angiogenesis Inhibitors administration & dosage, Antibodies, Monoclonal, Humanized administration & dosage, Macular Degeneration drug therapy, Off-Label Use ethics, Practice Patterns, Physicians' ethics, Practice Patterns, Physicians' standards, Practice Patterns, Physicians' statistics & numerical data, Practice Patterns, Physicians' trends, Truth Disclosure ethics
Published
2015
Full Text
View/download PDF

3. Why have UK doctors been deterred from prescribing Avastin?

Author

Cohen D

Subjects
Angiogenesis Inhibitors economics, Antibodies, Monoclonal, Humanized economics, Bevacizumab, Humans, United Kingdom, Wet Macular Degeneration economics, Angiogenesis Inhibitors therapeutic use, Antibodies, Monoclonal, Humanized therapeutic use, Drug and Narcotic Control, Off-Label Use economics, Off-Label Use ethics, Off-Label Use legislation & jurisprudence, Practice Patterns, Physicians' economics, Practice Patterns, Physicians' ethics, Practice Patterns, Physicians' legislation & jurisprudence, State Medicine economics, State Medicine ethics, State Medicine legislation & jurisprudence, Wet Macular Degeneration drug therapy
Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results